Verici DX (VRCI) Share Price

Health Care Sector


NOTE: This is based on 11 open tips for Verici DX (VRCI)


Verici DX (VRCI)
Latest Quote Price

1.62p

Verici DX (VRCI)
Price Change (%)

-4.62%


Latest Bid : 1.50p Latest Ask : 1.75p
High Today : 1.75p Low Today : 1.50p
This Years High : 8.35p This Years Low : 1.38p
Volume : 73,327 MKT Cap : £3.92M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Verici DX (VRCI) Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.

Verici DX (VRCI) Latest Tips

Type Tipster SectorScore Start date Performance
Avoid Steve Moore Premium Only 2025-04-07 11:10:00 07/04/2025 -8.33%
Avoid Steve Moore Premium Only 2024-10-11 14:50:00 11/10/2024 67.50%
Avoid Steve Moore Premium Only 2024-02-14 16:05:00 14/02/2024 80.88%
Avoid Steve Moore Premium Only 2023-11-15 14:35:00 15/11/2023 81.94%
Avoid Steve Moore Premium Only 2023-07-20 16:25:00 20/07/2023 85.87%

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Verici DX (VRCI) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 1.50p Latest Ask : 1.75p
High Today : 1.75p Low Today : 1.50p
This Years High : 8.35p This Years Low : 1.38p
Volume : 73,327 MKT Cap : £3.92M

Verici DX Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Verici DX Tips

Type Tipster SectorScore Start date Performance
Avoid Steve Moore Premium Only 2025-04-07 11:10:00 07/04/2025 -8.33%
Avoid Steve Moore Premium Only 2024-10-11 14:50:00 11/10/2024 67.50%
Avoid Steve Moore Premium Only 2024-02-14 16:05:00 14/02/2024 80.88%
Avoid Steve Moore Premium Only 2023-11-15 14:35:00 15/11/2023 81.94%
Avoid Steve Moore Premium Only 2023-07-20 16:25:00 20/07/2023 85.87%